|
|
|
Insider
Information: |
Lubatkin Veronica |
Relationship: |
Director |
City: |
Woodcliff Lake |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
148,812 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$137,488 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
148,812 |
|
|
Total
Value |
$137,488 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Par Pharmaceutical Companies Inc |
PRX |
EVP, Chief Financial O... |
2008-12-31 |
50,606 |
|
0 |
Premium* |
|
Interpace Biosciences Inc |
IDXG |
Director |
2013-06-04 |
98,206 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRX |
Par Pharmaceutical Compan... |
Executive Vice Pres & CFOOffic |
|
2007-06-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
23,000 |
|
- |
|
IDXG |
Interpace Biosciences Inc |
Director |
|
2008-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,019 |
|
- |
|
PRX |
Par Pharmaceutical Compan... |
Exec VP, CFO |
|
2008-01-11 |
4/A |
A |
$0.00 |
$0 |
D/D |
36,849 |
74,025 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Exec VP and CFO |
|
2008-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
36,849 |
69,639 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Exec VP and CFO |
|
2008-04-21 |
4 |
D |
$17.70 |
$11,841 |
D/D |
(669) |
72,101 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Chief Financial Officer |
|
2008-12-22 |
4 |
D |
$12.43 |
$16,843 |
D/D |
(1,355) |
70,746 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP and CFO |
|
2008-03-24 |
4 |
D |
$18.37 |
$23,054 |
D/D |
(1,255) |
72,770 |
0 |
- |
|
IDXG |
Interpace Biosciences Inc |
Director |
|
2010-06-03 |
4 |
A |
$7.91 |
$45,000 |
D/D |
5,689 |
31,970 |
0 |
- |
|
IDXG |
Interpace Biosciences Inc |
Director |
|
2009-06-04 |
4 |
A |
$3.67 |
$45,002 |
D/D |
12,262 |
26,281 |
0 |
- |
|
IDXG |
Interpace Biosciences Inc |
Director |
|
2011-05-31 |
4 |
A |
$6.90 |
$45,002 |
D/D |
6,522 |
38,492 |
0 |
- |
|
IDXG |
Interpace Biosciences Inc |
Director |
|
2013-06-04 |
4 |
A |
$4.47 |
$45,004 |
D/D |
10,068 |
54,137 |
0 |
- |
|
IDXG |
Interpace Biosciences Inc |
Director |
|
2012-06-05 |
4 |
A |
$8.07 |
$45,006 |
D/D |
5,577 |
44,069 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Chief Financial Officer |
|
2008-12-31 |
4 |
D |
$13.41 |
$270,077 |
D/D |
(20,140) |
50,606 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|